By Tom Zanki ( May 15, 2015, 4:21 PM EDT) -- Allergy-focused Circassia Pharmaceuticals PLC said Friday it's expanding into asthma products with the purchase of Swedish medical diagnostics company Aerocrine AB and clinical-stage-drug maker Prosonix Ltd for a total of £239 million ($376 million) cash, funded through new shares....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.